SLC2A4 and Insulin resistance: Ang II inhibits the insulin-induced activation of the PI3K pathway, leading to a reduction in endothelial nitric oxide (NO) production and Glut-4 translocation in insulin-sensitive tissues, resulting in insulin resistance [22, 23].